Last 499.10 GBp
Change Today -1.40 / -0.28%
Volume 10.0K
As of 11:35 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

nmc health plc (NMC) Snapshot

Open
511.00 GBp
Previous Close
500.50 GBp
Day High
511.00 GBp
Day Low
499.10 GBp
52 Week High
03/7/14 - 546.50 GBp
52 Week Low
06/26/13 - 263.00 GBp
Market Cap
926.9M
Average Volume 10 Days
47.2K
EPS TTM
0.37 GBp
Shares Outstanding
185.7M
EX-Date
05/28/14
P/E TM
22.8x
Dividend
4.89 GBp
Dividend Yield
0.91%
Current Stock Chart for NMC HEALTH PLC (NMC)

Related News

No related news articles were found.

nmc health plc (NMC) Related Businessweek News

No Related Businessweek News Found

nmc health plc (NMC) Details

NMC Health plc, together with its subsidiaries, provides professional medical services to the private sector in the United Arab Emirates. The company operates through two segments, Healthcare, and Distribution and Services. The Healthcare segment offers professional medical services comprising diagnostic services and hospital management services, as well as retails pharmaceutical goods and operates in and outpatient clinics. It operates four hospitals, two day surgeries, a medical centre, and eight in-hospital pharmacies, as well as a hospital under an operations and management contract in Abu Dhabi, Al Ain, Dubai, Sharjah, and Umm Al Quwain. The Distribution and Services segment is engaged in the wholesale trading of fast moving consumer goods, pharmaceuticals, medical equipment, foodstuff, veterinary products, analytical lab equipment, medical consumables and disposables, educational resources, and cosmetics. The company was founded in 1975 and is based in Abu Dhabi, United Arab Emirates.

5,356 Employees
Last Reported Date: 02/24/14
Founded in 1973

nmc health plc (NMC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nmc health plc (NMC) Key Developments

Khalifa Bin Butti Decided to Step Down from the NMC Health Plc's Board with Effect from 25 March 2014

NMC Health Plc announced that Mr. Khalifa Bin Butti has decided to step down from the Board with effect from 25 March 2014. Khalifa Bin Butti has been an Executive Director of NMC Health since 2011, and played a key role in bringing the Company onto the premium segment of the London Stock Exchange in April 2012. Since then he has served as Executive Vice Chairman and Director on the Board, helping steer the Company through a successful first two years as a public entity. Now that the Company is established as a successful listed entity with an impressive record of improving results he has decided to step down from the Board.

NMC Health Plc Recommends Final Dividend Payable on July 3, 2014; Reports Consolidated Earnings Results for Full Year Ended December 31, 2013

NMC Health Plc's Board recommended that a final dividend of 4.4 pence per share be paid in cash in respect of the year ended December 31, 2013. Subject to shareholder's approval with ex-dividend date of May 28, 2014, Record date May 30, 2014 and Payment date July 3, 2014. The company reported consolidated earnings results for full year ended 31 December 2013. For the period, revenue was $550,878,000 against $490,053,000 a year ago. Profit from operations before operations before depreciation and impairment was $92,940,000 against $79,619,000 a year ago. Profit for the period before tax was $69,143,000 against $59,766,000 a year ago. Profit for the year was $69,143,000 or $0.367 per basic and diluted share against $59,766,000 or $0.343 per basic and diluted share a year ago. Net cash from operating activities was $85,071,000 against $35,267,000 a year ago. Purchase of property and equipment was $78,616,000 against $105,277,000 a year ago. Net debt as on 31 December 2013 was $63.7 million against $46.1 million as on 31 December 2012. EBITDA was $92.9 million against $79.6 million a year ago. Total capital expenditure in period was $82.7 million against $118.9 million a year ago.

NMC Health Announces Changes to the Board

NMC Health Plc announced changes to the Board of NMC, all of which are effective from 24 February 2014. His Excellency Saeed Mohamed Butti Mohamed Al Qebaisi has decided to step down as a Director of the Company in view of the heavy demands on his time. As an incidental result of this decision, the appointment of Keyur Nagori as an Alternate Director to His Excellency also ceases with effect from the same date. Under the terms of the Relationship Agreement between the principal shareholders of NMC and the Company dated 2 April 2012, His Excellency Saeed Mohamed Butti Mohamed Al Qebaisi has nominated Abdulrahman Basaddiq to be a Director of the Company. Following the nomination by His Excellency, the Board of the Company has appointed Abdulrahman Basaddiq as a Director of the Company. Basaddiq is a fellow of the Institute of Chartered Accountants in England & Wales (FCA) and a licensed auditor and consultant in the UAE. He trained and qualified as a chartered accountant with Ernst & Young, London and spent over 25 years with Ernst & Young in the UK and the GCC, 15 of those as an equity partner. During his period at Ernst & Young, Abdulrahman served as the Managing Partner of their Riyadh and Abu Dhabi offices, in addition to responsibilities as UAE Country partner in charge. During his tenure in Riyadh, he oversaw the development and implementation of the only Saudisation program within the profession in the Kingdom at the time. He also served as an elected member of the firm's executive committee for some eight years, in addition to serving on the human resources committee for a number of years. Basaddiq spent over 12 years with a number of Gulf based diversified groups across multiple jurisdictions and sectors including healthcare, global public and private equities, venture capital, real estate investment, development and construction, steel trading and fabrication, in addition to food manufacturing, retail and packaging. He also spent over five years serving on two audit committees, chairing one of them., in addition to oversight responsibilities in the development of audit committees and the related internal audit functions of other entities, which have grown in size and complexity, to comply with the ever increasing governance and other regulatory demands.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NMC:LN 499.10 GBp -1.40

NMC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NMC.
View Industry Companies
 

Industry Analysis

NMC

Industry Average

Valuation NMC Industry Range
Price/Earnings 22.9x
Price/Sales 2.8x
Price/Book 4.0x
Price/Cash Flow 20.0x
TEV/Sales 2.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NMC HEALTH PLC, please visit www.nmc.ae. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.